Keros Therapeutics
KROS
#7006
Rank
C$0.56 B
Marketcap
$14.03
Share price
-0.70%
Change (1 day)
-83.68%
Change (1 year)

EPS for Keros Therapeutics (KROS)

EPS in 2023 (TTM): -$6.12

According to Keros Therapeutics's latest financial reports the company's current EPS (TTM) is -$6.43. In 2022 the company made an earnings per share (EPS) of -$5.87 a decrease over its 2021 EPS that were of -$3.57.

EPS history for Keros Therapeutics from 2019 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$6.124.24%
2022-$5.8764.68%
2021-$3.574.65%
2020-$3.4171.14%
2019-$1.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.09-51.98%๐Ÿ‡บ๐Ÿ‡ธ USA